Blockchain Registration Transaction Record

AXIM & MJNA Forge Alliance to Develop Water-Soluble Cannabinoid Breakthrough

AXIM Biotechnologies partners with Medical Marijuana Inc. to develop water-soluble cannabinoid technology that improves absorption 300x. Could revolutionize medical cannabis treatments.

This development matters because it addresses one of the most significant limitations in cannabinoid medicine: poor bioavailability due to water insolubility. Traditional cannabinoid treatments often require high doses because the body absorbs them inefficiently, leading to inconsistent effects and potential side effects. The 300-fold improvement in water solubility could dramatically enhance treatment efficacy for conditions like anxiety, seizures, and chronic pain while potentially reducing required dosages. For patients, this means more predictable, effective treatments with fewer side effects. For the medical cannabis industry, it represents a technological leap that could legitimize cannabinoid therapies in mainstream medicine by solving fundamental delivery challenges. The partnership combines AXIM's patented molecular engineering with MJNA's market expertise, accelerating the path from laboratory breakthrough to actual patient treatments.